Suresh Siddhanti

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

Steven R. Cummings, Javier San Martín, Michael R. McClung et al. · New England Journal of Medicine · 2009 · 3.4K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

David L. Kendler, Christian Roux, Claude Laurent Benhamou et al. · Journal of Bone and Mineral Research · 2009 · 451 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16

Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD

E. Michael Lewiecki, Paul D. Miller, Michael R. McClung et al. · Journal of Bone and Mineral Research · 2007 · 317 citations · Full text

Medicine, Clinical Sciences, Bone Metabolism +15

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

Nick Freemantle, Sacha Satram‐Hoang, En‐Tzu Tang et al. · Osteoporosis International · 2011 · 283 citations · Full text

Pharmacy, Pharmacotherapy, Pain Medicine +16

Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study

Ethel S. Siris, Steven T. Harris, Richard Eastell et al. · Journal of Bone and Mineral Research · 2005 · 242 citations

Medicine, Oncology, Pharmacotherapy +17